RankAlpha logo
Back to Rankings

NCEL

NewcelXF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
NCEL vs peer average
32/100
NCEL vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

QNCX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $17.12M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerQNCXQuince Therapeutics
NCEL
NewcelX
QNCX
Quince Therapeutics
Grade
F
B
Momentum
18
74
Value
41
41
Sentiment
-
50
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs QNCX

NCEL / QNCX
Grade Position
Below peers
NCEL vs. peer average (F vs. D)
32/100
Momentum
18
QNCX
Value
41
NCEL
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NCEL
1
QNCX
Quince Therapeutics Inc Common
B
80/100
-3
2
LPCN
Lipocine Inc Common
A
100/100
-4
3
GTBP
GT Biopharma Inc Common
D
40/100
-1
4
AKTX
Akari Therapeutics Plc ADR
D
40/100
-1
5
PASG
Passage Bio Inc Common
F
20/100
Even
QNCX is the first peer returned for this comparison set.